IPSC vs AMGN: Which Stock is Better?
Side-by-side comparison of Century Therapeutics Inc and Amgen Inc in 2026
IPSC
Century Therapeutics Inc
$2.59
AMGN
Amgen Inc
$349.39
Key Metrics Comparison
| Metric | IPSC | AMGN | Winner |
|---|---|---|---|
| Market Cap | $425.94M | $187.71B | AMGN |
| P/E Ratio | N/A | 24.45 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | 12.4% | 70.8% | AMGN |
Analyze IPSC
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPSC or AMGN a better investment?
Comparing IPSC and AMGN: Century Therapeutics Inc has a market cap of $425.94M while Amgen Inc has $187.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPSC and AMGN?
IPSC (Century Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPSC or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPSC or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for IPSC.
Which company is more profitable: IPSC or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 12.4% for IPSC.
Which is the larger company: IPSC or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $187.71B compared to $425.94M for IPSC.
Should I buy IPSC or AMGN in 2026?
Both IPSC and AMGN have investment merit. IPSC trades at $2.59 while AMGN trades at $349.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPSC and AMGN stock?
Key differences: Market Cap ($425.94M vs $187.71B), P/E Ratio (N/A vs 24.5x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (12.4% vs 70.8%).